Salute e Benessere

K-Beauty Shines as COSRX Snail Mucin Essence Claims No.1 on Amazon UK During…

Its 96% snail mucin formula helps repair the skin barrier, ease dryness and irritation, and revives a radiant glow, all with a lightweight gel texture that absorbs effortlessly. The essence has also become a global social media phenomenon, propelled by millions of TikTok views and compelling user-generated before-and-after content. This blend of clinical performance and viral community proof has cemented its cult status among dermatology enthusiasts, beauty creators, and loyal consumers. Its...
PR Newswire
27/11/2025

Once-Monthly GLP-1 RA | Gan & Lee Pharmaceuticals Initiates Phase 3 Clinical…

Previously, Gan & Lee has conducted two phase 3 clinical studies (GRADUAL-1 and GRADUAL-2) of bofanglutide injection for weight management in adults with obesity or overweight. In GRADUAL-2 study, bofanglutide injection is the first GLP-1 RA globally to be evaluated in a head-to-head, parallel-group comparison with semaglutide 2.4 mg (Wegovy®) in Chinese adults with obesity or overweight, with or without type 2 diabetes. These studies are designed to comprehensively assess and confirm the…
PR Newswire
27/11/2025

Neuraxpharm and mjn-neuro announce plans to launch EPISERAS®, a digital health…

Interim data from the ongoing SERAS-Home_RWD clinical study currently being prepared for publication Interim data from the ongoing SERAS-Home_RWD clinical study currently being prepared for publication BARCELONA, Spainand DÜSSELDORF,Germany , Nov. 27, 2025 /PRNewswire/ --Neuraxpharm Group(Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, andmjn-neuro, a start-up that designs, manufactures...
PR Newswire
27/11/2025

European Medicines Agency (EMA) grants Orphan Drug Designation to Kedrion's…

Aceruloplasminemiais an autosomal recessive disorder caused by mutations in the CP gene, leading to a deficiency or absence of Ceruloplasmin, a key plasma protein essential for iron transport. Without treatment, iron accumulates in the brain, liver, and pancreas, causing severe neurological symptoms, diabetes, anemia, and retinal degeneration.Source : Orphanethttps://www.orpha.net/en/disease/detail/48818 EMA's decision highlightsKedrion's role as a science-driven innovator...
PR Newswire
27/11/2025

Xinhua Silk Road: Exhibition on China's Dehua white porcelain opens in Los…

Addressing the event, Huang Hongjiang, deputy consul general of China in Los Angeles, said Dehua porcelain represents not only China's long-standing cultural traditions but also its refined modern craftsmanship. Addressing the event, Huang Hongjiang, deputy consul general ofChinainLos Angeles, said Dehua porcelain represents not onlyChina'slong-standing cultural traditions but also its refined modern craftsmanship. Huang saidChina'supcoming 15th Five-Year Plan offers broad...
PR Newswire
27/11/2025

Zelluna ASA: Disclosure of large shareholding

Reference is made to the stock exchange announcement made by Zelluna ASA (the "Company") on 3 November 2025 regarding the allocation of 5,500,000 new shares in the Company in a private placement (the "Private Placement"), divided on a first tranche of 3,729,774 new shares and a second tranche of 1,770,226 new shares ("Tranche 2"), and the allocation of 315,639 new shares in a retail offering via the PrimaryBid Platform. Radforsk Investeringsstiftelse…
Nasdaq GlobeNewswire
27/11/2025

71,498 Orion Corporation A shares converted into B shares

ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE27 NOVEMBER 2025 at 9.00 EET 71,498 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 71,498 A shares have been converted into 71,498 B shares. The conversion has been entered into the Trade Register on 27 November 2025.The total number of shares in Orion Corporation is 141,134,278...
Nasdaq GlobeNewswire
27/11/2025

Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M

Preliminary pharmacokinetic and safety evaluations of LPT-CBD in minipigs, provide encouraging support for Innocan's regulatory strategy to advance LPT-CBD IND-enabling studies in alignment with FDA standards. Preliminary pharmacokinetic and safety evaluations of LPT-CBD in minipigs, provide encouraging support for Innocan's regulatory strategy to advance LPT-CBD IND-enabling studies in alignment with FDA standards. In addition, meaningful pre-clinical data provides clinically translatable...
PR Newswire
27/11/2025

Aphranel Debuts at SAAM 2025, Spotlighting Original CaHA and the MagiCConcept…

SAAM 2025, one of the Middle East's most influential aesthetic medicine conferences, drew more than 2,500 participants from the United States, Germany, Switzerland, the Middle East, and other regions, spanning aesthetic dermatology, laser therapies, plastic surgery, and medical aesthetics. Aphranel's presence alongside Chinese experts highlights the growing integration of China's aesthetic technologies and treatment concepts into global practice. SAAM 2025, one of theMiddle East'smost...
PR Newswire
27/11/2025

Elanco executive appointed as Neurizon's Board Observer

Ms Conway is a seasoned healthcare professional with more than two decades of experience across the animal health and healthcare industries. She joined Elanco in 2020 as Global Head of Business Development, following an extensive investment banking career with Macquarie Bank and Bank of America Merrill Lynch, where she held senior roles across Sydney, London and New York. Ms Conway is a seasoned healthcare professional with more than two decades of experience across the animal health and...
PR Newswire
27/11/2025

Mycosis Fungoides Market Set to Expand by 2034 with Advancements in Targeted and…

Mycosis Fungoides Market Summary Mycosis Fungoides Market Summary Discover the mycosis fungoides new treatment @New Treatments for Mycosis Fungoides Key Factors Driving the Growth of the Mycosis Fungoides Market Increasing Prevalence of Mycosis Fungoides The mycosis fungoides market is expanding due to a rising number of mycosis fungoides cases, which is the most common type of cutaneous T-cell lymphoma. Studies have shown a steady increase in the incidence of this...
PR Newswire
26/11/2025

Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025…

COPENHAGEN, Denmark, November 26, 2025– Bavarian Nordic A/S invites its shareholders for a meeting and dialogue with the company’s board and management, who will provide the state of business and give a recap of the company’s strategy.The meeting will take place at Tivoli Hotel & Congress Center, Arni Magnussons Gade 2, DK-1577 Copenhagen V, Denmark on December 11, 2025 from 09:00 am to 10:30 am CET. The meeting will be held in English.Anyone who is registered as a shareholder in...
Nasdaq GlobeNewswire
26/11/2025

Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine…

The first step of this proactive approach involved the development of a cross-functional core team comprised of subject matter experts from Regulatory Affairs, Central Quality, R&D, and Manufacturing. These experts offered specialized insights from their unique perspective, interpreted regulatory guidance as it was published, and ensured every operation across our organization remains compliant with international NDSRI guidelines. The first step of this proactive approach involved the...
PR Newswire
26/11/2025

Metered Dose Inhalers Market to Reach $18.4 billion, Globally, by 2034 at 6.2%…

MDIs are popular across hospitals, clinics, and home care settings due to their portability, ease of use, and effective drug delivery mechanism. The increasing global burden of respiratory diseases, rising air pollution levels, growing geriatric population, and advancements in inhaler technology are driving the adoption of MDIs. The market is further supported by innovations such as breath-actuated MDIs and the integration of dose counters to enhance treatment compliance and monitoring. MDIs...
PR Newswire
26/11/2025

Valneva to Further Consolidate its Operations in France 

French operations to be concentrated at its Lyon site Final consolidation of R&D in Vienna Saint-Herblain (France), November 26 , 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced a strategic initiative to optimize its organizational footprint in France as part of the Company’s ongoing efforts to increase operational effectiveness and position Valneva for long-term success. The Company plans to concentrate its French operations...
Nasdaq GlobeNewswire
26/11/2025

Spinal Implants And Surgery Devices Market is expected to generate a revenue of…

For a detailed analysis of Industry Trends And Growth Drivers, Explore The Full Spinal Implants And Surgery Devices Market. For a detailed analysis of Industry Trends And Growth Drivers, Explore The Full Spinal Implants And Surgery Devices Market . Browse in-depth TOC 202 – Pages 126 – Tables 37 – Figures Global Spinal Implants And Surgery Devices Market Overview Market Driver 1. Rising Prevalence of Degenerative Spinal Disorders 2. Increased...
PR Newswire
26/11/2025

Airway Management Devices Market to Reach USD 3.82 Billion by 2031 as Global…

Download PDF Brochure: https://www.datamintelligence.com/download-sample/airway-management-devices-market Download PDF Brochure:https://www.datamintelligence.com/download-sample/airway-management-devices-market Browse in-depth TOC on 'Airway Management Devices Market' 62 – Tables 59 – Figures 159 – Pages A New Era of Respiratory Stabilization: Why the Market Is Strengthening 1. Rising Respiratory Disease Burden Over544 million people worldwidelive with...
PR Newswire
26/11/2025

Gummy Supplements Market to Reach USD 66.79 Billion by 2031 as Consumer Shift…

The market's growth is further amplified by rising lifestyle-related deficiencies, expanding preventive healthcare initiatives, social media–driven wellness culture, and the strong uptake of personalized nutrition products. The market's growth is further amplified by rising lifestyle-related deficiencies, expanding preventive healthcare initiatives, social media–driven wellness culture, and the strong uptake of personalized nutrition products. Download PDF Brochure:https://www...
PR Newswire
26/11/2025

Intraocular Lens Market worth $6.17 billion by 2030 with 6.0% CAGR |…

Browse in-depth TOC on "Intraocular Lens Market" 222 - Tables 50 - Figures239 - Pages Browse in-depth TOC on "Intraocular Lens Market" 222 - Tables50 - Figures 239 - Pages By Type,Aspheric monofocal IOLs hold the largest market share because they offer reliable visual outcomes, improved contrast sensitivity, and reduced spherical aberrations at an affordable cost. Their strong clinical performance, wide surgeon preference, and broad reimbursement coverage make...
PR Newswire
26/11/2025

Mural Health Expands Offering to Include Meal Delivery Services for Clinical…

"At Mural Health, we are continually looking for new ways to remove friction from the participant experience," said Sam Whitaker, Co-Founder & CEO of Mural Health. "Introducing meal delivery services is a natural extension of that commitment. By helping ensure participants have access to nutritious meals of their choice, we're reducing yet another burden that can make trial participation difficult, and reinforcing our belief that every participant deserves care and…
PR Newswire
26/11/2025

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights…

Offer set to expire at 9:00 am Eastern Time on December 3, 2025, with CureVac shareholders advised to tender their shares by 6:00 pm Eastern Time on December 2, 2025, due to operational deadlines.Exchange ratio of 0.05363 of a BioNTech American Depositary Share (“ADS”) for each CureVac share, determined based on the volume-weighted average price of BioNTech ADSs over the 10 trading days ending November 25, 2025.CureVac shareholders approved matters related to BioNTech’s exchange...
Nasdaq GlobeNewswire
26/11/2025

Oral Care Market Poised to Grow to USD 86.8 Billion by 2035 with a Thriving CAGR…

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.vantagemarketresearch.com/oral-care-market-1650/request-sample The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.vantagemarketresearch.com/oral-care-market-1650/request-sample Free Sample Includes: Oral Hygiene Moves from Routine to Intelligent Wellness The oral care ecosystem is undergoing a...
PR Newswire
26/11/2025

Kanazawa University research: Scientists develop light-controlled method to…

The team led by Satoshi Arai demonstrated that embedding vanadium phthalocyanine dye (VPc) into liposome membranes allows light-induced local heating confined at the molecular level (Figure1). Unlike conventional temperature-sensitive liposomes, which rely on bulk heating, this approach enables reversible and highly localized release of cargo molecules without causing widespread thermal damage. The team led bySatoshi Araidemonstrated that embedding vanadium phthalocyanine dye (VPc) into...
PR Newswire
26/11/2025

Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of…

The Company expects to initiate first-in-human study in early 2026, with initial data anticipated H2 2026Clinical Trial Application (CTA) submission marks the advancement of Tangram’s GalOmic RNAi platform into clinical development LONDON, Nov.26, 2025(GLOBE NEWSWIRE) -- Tangram Therapeutics (‘Tangram’), a company committed to uniting computation and RNAi to make better medicines faster, today announced the submission of a Clinical Trial Application (CTA) to the Medicines and...
Nasdaq GlobeNewswire
26/11/2025
Altri  Comunicati